IGC Pharma sells 588,235 shares to director-owned entity for $200,000 at $0.34 each

IGC Pharma, Inc.

Shares issued to Moran Global Strategies, owned by director James Moran, at $0.34/share.
Total proceeds of $200,000; closing subject to NYSE American approval.
Outstanding shares post-closing will be ~75,953,296; no warrants or options outstanding.
Investor receives piggyback registration rights with expense cap of $2,500.
Shares issued under Section 4(a)(2) exemption from registration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.